NDC properties for "timolol PF 0.25 % Ophthalmic Solution" (RxCUI 1922876)
About this data
The tables show NDC propoerties for timolol PF 0.25 % Ophthalmic Solution with the RxCUI 1922876
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for timolol PF 0.25 % Ophthalmic Solution (RxCUI 1922876)
| ANDA | ANDA216533 |
|---|---|
| MMSL_CODE | BD33264 |
| MMSL_CODE | CD33264 |
| RxCUI | 1922876 |
| SPL_SET_ID | 4c4318b3-9865-4172-a7bd-9e68913eca1e |
| VUID | 4013430 |
| Prescribable Synonym | timolol PF 0.25 % Ophthalmic Solution |
| RXNAV_STR | Preservative-Free timolol 2.5 MG/ML Ophthalmic Solution |
| RxNorm Name | Preservative-Free timolol 2.5 MG/ML Ophthalmic Solution |
| RxNorm Synonym | timolol PF 0.25 % Ophthalmic Solution |
| RxNorm Synonym | timolol PF 2.5 MG/ML (as timolol maleate 3.4 MG/ML) Ophthalmic Solution |
| Related queries | Interactions (for RxCUI 1922876) |
NDC Properties
NDC Item 50742028704
| NDC 9 | 50742-287 |
|---|---|
| NDC 10 | 50742-287-04 |
| NDC Item | 50742028704 |
| Packaging | 0.3 mL in 1 CONTAINER |
| Packaging | 4 in 1 POUCH |
| ANDA | ANDA216533 |
| FDA SPL set id | 749629 |
| Labeler | Ingenus Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50742-287 |
NDC Item 50742028760
| NDC 9 | 50742-287 |
|---|---|
| NDC 10 | 50742-287-60 |
| NDC Item | 50742028760 |
| Packaging | 15 POUCH in 1 CARTON (50742-287-60) / 4 CONTAINER in 1 POUCH (50742-287-04) / .3 mL in 1 CONTAINER |
| ANDA | ANDA216533 |
| FDA SPL set id | 749629 |
| Labeler | Ingenus Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50742-287 |
NDC Item 50742028704
| NDC 9 | 50742-287 |
|---|---|
| NDC 10 | 50742-287-04 |
| NDC Item | 50742028704 |
| Packaging | 0.3 mL in 1 CONTAINER |
| Packaging | 4 in 1 POUCH |
| ANDA | ANDA216533 |
| FDA SPL set id | 749629 |
| Labeler | Ingenus Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50742-287 |
NDC Item 50742028760
| NDC 9 | 50742-287 |
|---|---|
| NDC 10 | 50742-287-60 |
| NDC Item | 50742028760 |
| Packaging | 15 POUCH in 1 CARTON (50742-287-60) / 4 CONTAINER in 1 POUCH (50742-287-04) / .3 mL in 1 CONTAINER |
| ANDA | ANDA216533 |
| FDA SPL set id | 749629 |
| Labeler | Ingenus Pharmaceuticals, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 50742-287 |